Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
SUMMARY Cancer mortality is primarily a consequence of its metastatic spread. Here we report that methionine sulfoxide reductase (MSRA), which can reduce oxidized methionine residues, acts as a suppressor of pancreatic ductal adenocarcinoma (PDA) metastasis. MSRA expression is decreased in the metastatic tumors of PDA patients, while MSRA loss in primary PDA cells promotes migration and invasion. Chemoproteomic profiling of pancreatic organoids revealed that MSRA loss results in selective oxidation of a methionine residue (M239) in pyruvate kinase M2 (PKM2). Moreover, M239 oxidation sustains PKM2 in an active tetrameric state to promote respiration, migration, and metastasis, while pharmacological activation of PKM2 increases cell migration and metastasis in vivo. These results demonstrate that methionine residues can act as reversible redox switches governing distinct signaling outcomes and that the MSRA-PKM2 axis serves as a regulatory nexus between redox biology and cancer metabolism to control tumor metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908 · cited 3×
“1(+) This study N/A mPKM2-Flag-pBABE-neo This study N/A EFS-Cas9-P2A-Puro Addgene Addgene#108100 roGFP2-Orp1 (Morgan et al., 2011) Tobias Dick lab Mito-roGFP-Orp1 (Morgan et al., 2011) Tobias Dick lab Grx1-roGFP2 (Morgan et al., 2011) Tobias Dick lab Mito-Grx1-roGFP2 (Morgan et al., 2011) Tobias Dick lab Software and…”
MethodInfluentialDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741 · cited 2×
“The design principle of sgRNA was based on previous reports: (1) sgRNAs with the predicted low off-target effect (Hsu et al., 2013) and (2) sgRNAs targeting the functional protein domain region (Shi et al.”
MethodElias, J. E., & Gygi, S. P. (2007) · Nature Methods · doi:10.1038/nmeth1019 · Cited by 3,925
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277 · cited 1×
“Mutant KRAS signaling drives tumorigenesis in part by inducing Nrf2, a transcription factor that governs the cellular antioxidant response and elevates the levels of endogenous antioxidants (DeNicola et al., 2011).”
BackgroundMoffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3398 · Cited by 2,194
Self-citationOrganoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150
Self-citationRos and ros-mediated cellular signaling
Zhang, J., Wang, X., Vikash, V., Ye, Q., Wu, D., Liu, Y., & Dong, W. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4350965 · Cited by 1,980 · cited 2×
“…been shown to scavenge ROS (Luo and Levine, 2009), we asked whether the downregulation of MSRA results in elevated global levels of ROS, which in turn might promote PDA metastasis by Molecular Cell 82, 3045–3060, August 18, 2022 3047 activating growth factor signaling pathways (Zhang et al., 2016).”
BackgroundComet: An open‐source MS / MS sequence database search tool
Eng, J. K., Jahan, T. A., & Hoopmann, M. R. (2013) · PROTEOMICS · doi:10.1002/pmic.201200439 · Cited by 1,474 · cited 2×
“Database searching used Comet version 2016.01 rev. 3 (Eng et al., 2013) with the PAW pipeline for peptide spectrum match (PSM) validation using the target/decoy method (Elias and Gygi, 2007).”
MethodInfluentialBirsoy, K., Wang, T., Chen, W. W., Freinkman, E., Abu-Remaileh, M., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.07.016 · Cited by 1,388
Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells
Sullivan, L. B., Gui, D. Y., Hosios, A. M., Bush, L. N., Freinkman, E., & Vander Heiden, M. G. (2015) · Cell · doi:10.1016/j.cell.2015.07.017 · Cited by 1,173
A Dynamic Pathway for Calcium-Independent Activation of CaMKII by Methionine Oxidation
Erickson, J. R., Joiner, M.-L. A., Guan, X., Kutschke, W., Yang, J., Oddis, C. V., Bartlett, R. K., Lowe, J. S., O'Donnell, S. E., Aykin-Burns, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.048 · Cited by 1,122
Self-citationOrganoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0349 · Cited by 1,092 · cited 2×
“Decreased MSRA expression in PDA cells was not observed at the transcript level upon analysis of publicly available transcriptomic data from laser-capture microdissected human tissues (Figure S1E) (Moffitt et al., 2015), murine (Figure S1F) (Roe et al., 2017), or human (Figure S1G; Tiriac et al., 2018) organoids.”
BackgroundSelf-citationRegulation of mammalian nucleotide metabolism and biosynthesis
Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1060 · Cited by 816 · cited 1×
“PKM2 activation promotes PDA metastasis PKM2 activators have been shown to suppress primary tumor formation in xenograft models (Anastasiou et al., 2012).”
BackgroundSelf-citationPyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
Hitosugi, T., Kang, S., Vander Heiden, M. G., Chung, T.-W., Elf, S., Lythgoe, K., Dong, S., Lonial, S., Wang, X., Chen, G. Z., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000431 · Cited by 784 · cited 2×
“The conformation of PKM2 is tightly controlled by allosteric factors that regulate the equilibrium between the less active dimeric state and highly active tetramers, allowing cellular metabolism to shift between glycolysis and mitochondrial respiration, respectively (Christofk et al., 2008b; Hitosugi et al., 2009).”
BackgroundSerine is a natural ligand and allosteric activator of pyruvate kinase M2
Chaneton, B., Hillmann, P., Zheng, L., Martin, A. C. L., Maddocks, O. D. K., Chokkathukalam, A., Coyle, J. E., Jankevics, A., Holding, F. P., Vousden, K. H., et al. (2012) · Nature · doi:10.1038/nature11540 · Cited by 661 · cited 1×
“Pyruvate kinase activity assay In vitro measurement of pyruvate kinase activity on proteins immunoprecipitated from HEK293T or murine pancreatic cancer cells was conducted as in Chaneton et al. (2012).”
MethodThe Two Faces of Reactive Oxygen Species in Cancer
Reczek, C. R., & Chandel, N. S. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-041916-065808 · Cited by 602 · cited 1×
“Although reactive oxygen species (ROS) have been implicated in tumor development, the fundamental relationships between redox biology and cancer remain poorly understood (Reczek and Chandel, 2017).”
BackgroundBACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
Wiel, C., Le Gal, K., Ibrahim, M. X., Jahangir, C. A., Kashif, M., Yao, H., Ziegler, D. V., Xu, X., Ghosh, T., Mondal, T., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.005 · Cited by 579
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells
Israelsen, W. J., Dayton, T. L., Davidson, S. M., Fiske, B. P., Hosios, A. M., Bellinger, G., Li, J., Yu, Y., Sasaki, M., Horner, J. W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.025 · Cited by 549 · cited 2×
“…and the genetic replacement of PKM2 with PKM1 in some mouse models has been shown to enhance tumor development (Dayton et al., 2016) and metastasis (Israelsen et al., 2013), the induction of pyruvate kinase activity may Molecular Cell 82, 3045–3060, August 18, 2022 3053 (A) Quantitative mass…”
BackgroundNRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378 · cited 7×
“To ascertain whether antioxidants can reverse the methionine oxidation status of PKM2 and impede cell migration, we then examined the impact of N-acetylcysteine (NAC), a global antioxidant, or MitoTempo, a mitochondria-targeted superoxide dismutase mimetic, on PDAT-sgMsrA cells.”
BackgroundMethodInfluentialSelf-citationMoskovitz, J., Rahman, M. A., Strassman, J., Yancey, S. O., Kushner, S. R., Brot, N., & Weissbach, H. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.3.502-507.1995 · Cited by 294 · cited 2×
“Two evolutionarily related oxidoreductases, methionine sulfoxide reductase A (MSRA) (Moskovitz et al., 1995) and B (MSRB) (Moskovitz et al.”
BackgroundYamaguchi, N., Weinberg, E. M., Nguyen, A., Liberti, M. V., Goodarzi, H., Janjigian, Y. Y., Paty, P. B., Saltz, L. B., Kingham, T. P., Loo, J. M., et al. (2019) · eLife · doi:10.7554/elife.52135 · Cited by 91 · cited 4×
“Several lines of evidence suggest that mitochondrial respiration is favored by metastatic cancer cells (Caino et al., 2015, 2016; Hooda et al., 2013; Kulawiec et al., 2009; LeBleu et al., 2014; Nie et al., 2020; Rademaker et al., 2019; Rodrigues et al., 2016; Yamaguchi et al., 2019; Zhou et al., 2018).”
BackgroundInfluentialNie, K., Li, J., He, X., Wang, Y., Zhao, Q., Du, M., Sun, H., Wang, J., Lyu, J., Fang, H., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-0231-2 · Cited by 64
Erratum: Asparagine bioavailability governs metastasis in a model of breast cancer
Knott, S. R. V., Wagenblast, E., Khan, S., Kim, S. Y., Soto, M., Wagner, M., Turgeon, M.-O., Fish, L., Erard, N., Gable, A. L., et al. (2018) · Nature · doi:10.1038/nature26162 · Cited by 12
Self-citation
Cited by
Targeting ROS in cancer: rationale and strategies
Glorieux, C., Liu, S., Trachootham, D., & Huang, P. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00979-4 · Cited by 651
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Chen, Y., Ouyang, Y., Li, Z., Wang, X., & Ma, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188891 · Cited by 165
Halliwell, B. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.098 · Cited by 87
The selenoprotein methionine sulfoxide reductase B1 (MSRB1)
Tarrago, L., Kaya, A., Kim, H.-Y., Manta, B., Lee, B.-C., & Gladyshev, V. N. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.08.043 · Cited by 39
Metadata
- Authors
- He, D., Feng, H., Sundberg, B., Yang, J., Powers, J., Christian, A. H., Wilkinson, J. E., Monnin, C., Avizonis, D., Thomas, C. J., Friedman, R. A., Kluger, M. D., Hollingsworth, M. A., Grandgenett, P. M., Klute, K. A., Toste, F. D., Chang, C. J., & Chio, I. I. C.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 82
- Issue
- 16
- Pages
- 3045-3060.e11
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W4283372776
- Cited by
- 78
- References
- 27
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.